CASE 6.3 ELLY LILLI IN INDIA: RETHINKING THE JOIN VENTURE STRATEGY Summary: The case consists of two major pharmaceutical companies that joint to collaborate their research and pharmaceutical technologies to start a joint venture in India. Both have valuable resources that have benefited both companies during the joint venture. Now both are questioning if there is still any value in maintaining the joint venture in India and will be deciding what will be the best route to take. Ranbaxy Laboratories
Words: 1152 - Pages: 5
Summary GlaxoSmithKline (GSK) is one of the main pharmaceutical and healthcare drug developer and manufacturer in the world. The product liability case with the British company, GSK includes the drugs Avandia, Paxil, Wellbutrin, and others (Thomas & Schmidt, 2012). The drug maker pleaded guilty and agreed to pay fines from the criminal charges in the case. GSK promoted its antidepressants for unapproved uses and failing to report safety data to the FDA on their diabetes drug. In addition, there
Words: 1317 - Pages: 6
Implementation Ranbaxy Laboratories Ltd 1. Summary: Indian pharmaceutical industry is estimated at $8 billion in 2013 and had been growing at an average rate of 8–9 %. The industry was highly fragmented with more than 1000 players out of which 30% of market was controlled by top ten companies and the rest of 70% by small companies. The Global pharmaceutical industry was estimated at $ 600 billion in 2013. Indian pharmaceutical industry has become more innovative and enterprising with more investment
Words: 11886 - Pages: 48
Business Research Ethics RES/351 Chimerix is a biopharmaceutical company dedicated to discovering, developing and commercializing novel, oral antivirals in areas of high unmet medical need. Since 2001, the organization has researched, developed and experimentally tested a virus-killing drug called Brincidofovir. Subsequently learning of the existence of the drug, a family requested that the company donate the drug to treat their little boy who contracted a deadly virus after receiving a bone-marrow
Words: 1065 - Pages: 5
BUS 616 week 1 Assignment Pfizer’s Drug Testing Strategy in Nigeria http://homeworktimes.com/downloads/bus-616-week-1-assignment-pfizers-drug-testing-strategy-nigeria/ Pfizer’s Drug-Testing Strategy in Nigeria Read Management Focus: Pfizer’s Drug-Testing Strategy in Nigeria in chapter 4 of your text and write a 3-4 page paper in APA format that answers the following questions: What are the different phases that a Drug Company goes through in order to bring a new drug product to market in the
Words: 571 - Pages: 3
Project Portfolio Management at XYZ Pharma Part 1- The objectives in the Project Portfolio Management include strategically organizing the importance of different issues within the company, focus more on the sales growth rather than the sales figure, and prioritize the research and development. The constraints that take place within the case are linked to the discovery of different drugs and the risks that follow. Also, John Smith mentioned lengthening and shortening the steps of developing
Words: 629 - Pages: 3
communication is the key. Poor communication skills could have a domino effect leading to unhappy employees, unsatisfied customers, missed deadlines and ultimately unhappy management. For example - the company I’m employed with works for larger Pharmaceutical companies to collect data, recruit investigative sites, and complete regulatory documents. The Pharma provides verbal and written communication regarding their expectation to team managers who than relay the information to team lead(s), which
Words: 272 - Pages: 2
Executive Summary: Pfizer-Wyeth Merger Deal Overview: On January 25, 2009, Pfizer and Wyeth entered into the merger agreement, pursuant to which, subject to the terms and conditions set forth in the merger agreement, Wyeth will become a wholly-owned subsidiary of Pfizer. Upon completion of the merger, each share of Wyeth common stock issued and outstanding will be converted into the right to receive, subject to adjustment under limited circumstances, a combination of $33.00 in cash, without interest
Words: 8308 - Pages: 34
The Pharmaceutical Industry 1. Origins and Evolution The modern pharmaceutical industry is a highly competitive non-assembled1 global industry. Its origins can be traced back to the nascent chemical industry of the late nineteenth century in the Upper Rhine Valley near Basel, Switzerland when dyestuffs were found to have antiseptic properties. A host of modern pharmaceutical companies all started out as Rhine-based family dyestuff and chemical companies e.g. Hoffman-La Roche, Sandoz, Ciba-Geigy
Words: 1706 - Pages: 7
BACKGROUND Thе currеnt rеport focusеs on mеdical еrrors in gеnеral, and morе spеcifically, medication errors. This problеm has a long history in hеalthcarе. As long as humans havе bееn in chargе of thе procеss of giving patiеnts mеdications, thе systеm has bееn pronе to human еrror. This is a complicatеd issuе bеcausе thеrе is always going to bе thе еlеmеnt of systеmic еrror in thе hеalthcarе еnvironmеnt. No tеchnologically sophisticatеd program rеally sееms to havе solvеd and totally
Words: 2754 - Pages: 12
